NOVEL INFLAMMATORY RISK MARKERS INCLUDING LPPLA2 AND RISK OF CHD IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH)

Geahča maid

• NOVEL INFLAMMATORY RISK MARKERS INCLUDING LPPLA2 AND RISK OF CHD IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH)
  Dahkki: Seed, M, et al.
  Almmustuhtton: (2009)
• Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia
  Dahkki: Neil, A, et al.
  Almmustuhtton: (2003)
• Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia
  Dahkki: Neil, H, et al.
  Almmustuhtton: (2003)
• Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia.
  Dahkki: Neil, H, et al.
  Almmustuhtton: (2004)
• CURRENT STATIN TREATMENT OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH): RESULTS FROM THE ROYAL COLLEGE OF PHYSICIANS UK NATIONAL AUDIT
  Dahkki: Seed, M, et al.
  Almmustuhtton: (2011)